{"subject":"郎慧珠 教授","pubUnitName":"醫務管理研究所","posterDate":"113-11-19","updateDate":"114-06-04","detailContent":"\r\n
\r\n
\r\n
\"郎慧珠\"
\r\n\r\n
 
\r\n
\r\n\r\n
\r\n
郎慧珠
\r\nLang, Hui-Chu
\r\n\r\n
\"\" (02)2826-7015
\r\n\r\n
\"\" hclang@nycu.edu.tw
\r\n\r\n
\"\" 教師個人CV
\r\n\r\n
\"office\"陽明校區護理館5樓521室
\r\n 
\r\n\r\n
學歷
\r\n\r\n
\r\n
    \r\n\t
  • 美國約翰霍普金斯大學醫療管理博士
    • \r\n\t
  • 國立陽明大學公共衛生碩士
    • \r\n\t
  • 中國醫藥大學公共衛生學士
    • \r\n
\r\n現職\r\n\r\n
    \r\n\t
  • 國立陽明大學醫務管理研究所教授
    • \r\n
\r\n
\r\n\r\n
經歷
\r\n\r\n
\r\n
    \r\n\t
  • 國立陽明大學醫務管理研究所 副教授
    • \r\n\t
  • 國立陽明大學醫務管理研究所 助理教授
    • \r\n\t
  • 國立陽明大學醫務管理研究所 講師
    • \r\n
\r\n研究興趣
\r\n成本效益評估、醫院績效管理
\r\n
\r\nPubMed之著作
\r\n\"Lang
\r\n代表著作\r\n\r\n
    \r\n\t
  1. Chiu CM, Chen MS, Lin CS, Lin WY, Lang HC*. Evaluating the comparative efficiency of medical centers in Taiwan: a dynamic data envelopment analysis application. BMC Health Serv Res. 2022 Apr 2;22(1):435. doi: 10.1186/s12913-022-07869-8.
    2. \r\n\t
  2. Chiou LJ, Lang HC*. Potentially preventable hospital readmissions after patients' first stroke in Taiwan. Sci Rep. 2022 Mar 8;12(1):3743. doi: 10.1038/s41598-022-07791-3. SCI/SSCI, IF= 4.38 / Q1 (19/128). MOST 105-2410-H-010 -012 -SS2.
    3. \r\n\t
  3. Yang CP, Li CY, Huang WJ, Yu HL, Yang CC, Lu MC, Lang HC*, Yan YH*. Short-, Mid-, and Long-Term Associations Between PM2.5 and Stroke Incidence in Taiwan. J Occup Environ Med. 2021 Sep 1;63(9):742-751. SCI/SSCI, IF=4.4 / Q1 (39/376). MOST 105-2410-H-010 -012 -SS2
    4. \r\n\t
  4. Yang CP, Cheng HM, Lu MC, Lang HC*. Association between continuity of care and long-term mortality in Taiwanese first-ever stroke survivors: An 8-year cohort study. PLoS One. 2019 May 22;14(5):e0216495. SCI/SSCI, IF=3.24 / Q1 (29/128). MOST 105-2410-H-010 -012 -SS2
    5. \r\n\t
  5. Cheng HM, Chiou LJ, Chen TC, Sung SH, Chen CH, Lang HC*. Real-world cost- effectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease-A five-year follow-up study. Health Policy. 2019 Feb;123(2):229-234. SCI/SSCI, IF=2.98 / Q2 (48/150). NSC 101-2410-H-010
    6. \r\n\t
  6. Lang HC, Chen HW, Chiou TJ, Chan AL. The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan. J Med Econ. 2016 Oct;19(10):923-7. SCI/SSCI, IF=2.45 / Q2 (63/150).
    7. \r\n\t
  7. Chang JY, Lang HC. The Econimic Cost of Rheumatoid Arthritis in Taiwan. Value Health. 2014 Nov;17(7):A773. doi: 10.1016/j.jval.2014.08.328. Epub 2014 Oct 26. SCI/SSCI, IF=5.73 / Q1 (51/557)
    8. \r\n\t
  8. Shih CL, Chen CH, Sheu CF, Lang HC*, Hsieh CL. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model. Value Health. 2013 Jul-Aug;16(5):848-54. doi: 10.1016/j.jval.2013.05.004. Epub 2013 Jul 17. PMID: 23947980. SCI/SSCI, IF=5.73 / Q1 (51/557).
    9. \r\n\t
  9. Lang HC, Chang K, Ying YH. Quality of life, treatments, and patients' willingness to pay for a complete remission of cervical cancer in Taiwan. Health Econ. 2012 Oct;21(10):1217-33. SCI/SSCI, IF=3.05 / Q1 (112/557).
    10. \r\n\t
  10. Lang HC*. Willingness to pay for lung cancer treatment. Value Health. 2010 Sep-Oct;13(6):743-9. SCI/SSCI, IF=5.73 / Q1 (51/557).
    11. \r\n
\r\n近期指導學生論文
\r\n碩士班\r\n\r\n
    \r\n\t
  • 臺灣2021年COVID-19疫苗施打政策之成本效益評估
    • \r\n\t
  • 肺癌低劑量電腦斷層掃描篩檢之成本效果評估
    • \r\n\t
  • 肺癌病人健康生活品質探討
    • \r\n\t
  • 比較腦中風患者接受急性後期照護或一般復健照護之費用與結果
    • \r\n\t
  • 免疫治療應用於治療化療後局部晚期或轉移性 非小細胞肺癌患者之成本效果評估
    • \r\n
\r\n碩士在職專班\r\n\r\n
    \r\n\t
  • 低劑量電腦斷層掃描肺癌篩檢前後的心理與健康行為
    • \r\n\t
  • 新冠肺炎重症住院患者使用Remdesivir成本效益分析
    • \r\n\t
  • 新冠肺炎大流行期間板橋加強版集中檢疫所之成效分析
    • \r\n\t
  • 運用雲端藥歷與世界衛生組織病人安全標準流程整合住院病人用藥之探討
    • \r\n\t
  • 以資料包絡分析法探討衛福部所屬醫療機構之經營績效
    • \r\n
\r\n
\r\n
\r\n
","languageUrl":null,"docs":[],"images":[],"videos":[],"audios":[],"resources":[]}